Yabao Pharmaceutical Group Co., Ltd (600351.SS)

Growth (Per Share)

Revenue 5Y
Revenue 3Y
Earnings 5Y
Earnings 3Y
Dividend 5Y
Dividend 3Y

Capital Efficiency

ROIC
ROE
ROA
ROTA

Capital Structure

Market Cap5.30B
EV5.30B
Cash
Current Ratio
Debt/Equity
Net Debt/EBITDA
Show More

Select a metric from the list below to chart it

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
275.2
300.9
263.1
372.7
425.0
443.1
379.1
402.6
395.9
411.4
Revenue % Chg.
16.3%
9.3%
-12.6%
41.7%
14.1%
4.2%
-14.4%
6.2%
-1.7%
-2.6%
Cost of Revenue
130.6
142.7
147.1
162.5
169.6
161.4
154.2
156.9
174.7
182.1
Gross Profit
144.6
158.2
116.0
210.1
255.4
281.7
224.8
245.7
221.2
229.3
Gross Profit Margin
52.5%
52.6%
44.1%
56.4%
60.1%
63.6%
59.3%
61.0%
55.9%
55.7%
R&D Expenses
8.2
7.9
12.3
20.5
16.3
16.4
21.0
22.9
19.0
19.3
Selling, General, & Admin Expenses
71.1
75.4
75.5
110.4
149.9
175.7
151.3
160.3
138.5
142.0
Other Expenses
31.9
36.4
32.6
37.8
34.2
32.1
29.0
29.9
32.4
31.7
Operating Income
33.5
38.4
-4.4
41.4
55.0
55.1
18.5
29.6
32.1
23.2
Operating Income Margin
12.2%
12.8%
-1.7%
11.1%
12.9%
12.4%
4.9%
7.4%
8.1%
5.6%
Total Other Income/Expenses Net
-5.8
-2.3
8.5
-8.6
-6.9
-47.9
0.0
-0.2
-13.8
1.4
Income Before Tax
27.7
36.1
4.1
32.7
48.1
7.3
18.6
29.4
18.3
24.6
Income Before Tax Margin
10.1%
12.0%
1.5%
8.8%
11.3%
1.6%
4.9%
7.3%
4.6%
6.0%
Income Tax Expense
3.6
4.3
0.1
3.6
6.7
5.7
2.7
2.6
3.1
3.8
Net Income
24.8
32.3
3.3
29.2
39.8
1.6
15.6
27.3
15.2
20.8
Net Income Margin
9.0%
10.8%
1.2%
7.8%
9.4%
0.4%
4.1%
6.8%
3.9%
5.1%
Weighted Avg. Shares Out
680.5
692.1
787.5
787.0
784.8
695.3
766.9
779.5
747.5
EPS
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
EPS % Chg.
47.1%
28.4%
-91.1%
789.5%
36.9%
-95.5%
803.2%
71.4%
-41.7%
Weighted Avg. Shares Out Dil
680.5
692.1
787.5
787.0
784.8
695.3
766.9
779.5
747.5
EPS Diluted
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
Interest Income
0.5
0.4
0.8
0.8
0.7
0.4
0.5
1.2
1.2
1.0
Interest Expense
7.3
7.7
5.0
6.2
5.5
7.0
4.7
3.3
2.7
2.7
EBIT
20.9
28.8
-0.2
27.3
43.2
0.7
14.3
27.3
16.8
22.9
EBIT Margin
7.6%
9.6%
-0.1%
7.3%
10.2%
0.2%
3.8%
6.8%
4.2%
5.6%
Depreciation & Amortization
18.3
19.7
23.0
25.5
25.0
25.2
30.6
31.0
23.9
14.3
EBITDA
39.2
48.5
22.8
52.7
68.2
25.8
45.0
58.3
40.6
37.2
EBITDA Margin
14.2%
16.1%
8.7%
14.2%
16.0%
5.8%
11.9%
14.5%
10.3%
9.0%